Watch for Tirzepatide for Sleep Apnea
April 2025
Tirzepatide (Zepbound) will be the first Rx med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults.
It’s only for patients with obesity who are working on lifestyle changes (healthy eating, increasing physical activity, etc).
Using tirzepatide 10 mg or 15 mg weekly for 1 year reduces breathing interruptions by about 20 episodes/hour more than placebo...in patients with or without concomitant continuous positive airway pressure (CPAP).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote